PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial
Introduction Tuberculosis (TB) continues to be one of the deadliest infectious diseases over the centuries, killing more people worldwide than any other single infectious disease. There is an urgent need for additional strategies which can expedite efforts to combat TB including a preventive vaccine...
Saved in:
Similar Items
-
TB or not TB?
by: Andrew Pirotte, et al.
Published: (2024-04-01) -
Study of Diabetes and Extrapulmonary Tuberculosis (Cervical Lymphoadenopathy, Skin TB, CNS TB, Plueural Tubercular Effusion)
by: Praveen K. Tagore, et al.
Published: (2025-06-01) -
Accelerating TB regimen development: introducing FAST-TB
by: T. Devezin, et al.
Published: (2024-11-01) -
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
by: Neeraj Raizada, et al.
Published: (2014-01-01) -
Occipital intradiploic epidermoid presenting as benign intracranial hypertension: A rare manifestation
by: Ranjan Kumar Sahoo, et al.
Published: (2013-09-01)